Xiaohong Pu

321 Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Inflammatory memory disables a DDR1 degradation checkpoint to enable pancreatic cancer growth.

Inflammatory memory disables a DDR1 degradation checkpoint to enable pancreatic cancer growth.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Multidimensional analysis of tumour immune microenvironment in HCC: prognostic significance and implications for immunotherapy.

Multidimensional analysis of tumour immune microenvironment in HCC: prognostic significance and implications for immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: January 13, 2026

GPC6 facilitates progression of SHH-subgroup medulloblastoma by enhancing Hedgehog secretion and signaling responses.

GPC6 facilitates progression of SHH-subgroup medulloblastoma by enhancing Hedgehog secretion and signaling responses.

Journal: Journal of biomedical research

Published: November 30, 2025

Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma.

Integrative multi-omics identifies cholangiolocarcinoma as a distinct molecular subtype of intrahepatic cholangiocarcinoma.

Journal: JHEP reports : innovation in hepatology

Published: October 26, 2025

FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma.

FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 12, 2025

Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma.

Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma.

Journal: Journal of hepatology

Published: December 20, 2024

HER2 amplification subtype intrahepatic cholangiocarcinoma exhibits high mutation burden and T cell exhaustion microenvironment.

HER2 amplification subtype intrahepatic cholangiocarcinoma exhibits high mutation burden and T cell exhaustion microenvironment.

Journal: Journal of cancer research and clinical oncology

Published: January 16, 2024

Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis.

Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis.

Journal: JCI insight

Published: September 26, 2023

Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma.

Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: September 13, 2023

Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements.

Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements.

Journal: Diagnostic pathology

Published: August 07, 2023

Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas.

Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas.

Journal: Cell & bioscience

Published: June 28, 2023

High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.

High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.

Journal: Cell proliferation

Published: March 18, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026